{
    "xml": "<topic id=\"PHP97002\" outputclass=\"drug\" rev=\"1.22\" type=\"drug\" namespace=\"/drugs/ethambutol-with-isoniazid-pyrazinamide-and-rifampicin\" basename=\"ethambutol-with-isoniazid-pyrazinamide-and-rifampicin\" title=\"ETHAMBUTOL WITH ISONIAZID, PYRAZINAMIDE AND RIFAMPICIN\">\n<title>ETHAMBUTOL WITH ISONIAZID, PYRAZINAMIDE AND RIFAMPICIN</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_165\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/isoniazid\">Isoniazid</xref>, <xref format=\"dita\" href=\"#bnf_int_201\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/rifamycins/rifampicin\">Rifampicin</xref>, <xref format=\"dita\" href=\"#bnf_int_192\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/pyrazinamide\">Pyrazinamide</xref>, <xref format=\"dita\" href=\"#bnf_int_1304\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/ethambutol\">Ethambutol</xref>\n</p>\r\n<p outputclass=\"constituentDrugs\">The properties listed below are those particular to the combination only. For the properties of the components please consider, <xref format=\"dita\" href=\"#PHP3604\" namespace=\"/drugs/ethambutol-hydrochloride\">ethambutol hydrochloride</xref>, <xref format=\"dita\" href=\"#PHP3608\" namespace=\"/drugs/isoniazid\">isoniazid</xref>, <xref format=\"dita\" href=\"#PHP3612\" namespace=\"/drugs/pyrazinamide\">pyrazinamide</xref>, <xref format=\"dita\" href=\"#PHP3619\" namespace=\"/drugs/rifampicin\">rifampicin</xref>.</p>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_574205566\" title=\"Antimycobacterials\">Antimycobacterials</xref>\n</data>\n</data>\r\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_622263057\" title=\"Hydrazines\">Hydrazines</xref>\n</data>\n</data>\r\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_467467039\" title=\"Rifamycins\">Rifamycins</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP97098\" outputclass=\"indicationsAndDose\" rev=\"1.14\" parent=\"/drugs/ethambutol-with-isoniazid-pyrazinamide-and-rifampicin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Initial treatment of tuberculosis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 30&#8211;39 kg)</p>\n<p>2&#8239;tablets daily for 2 months (initial phase).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 40&#8211;54 kg)</p>\n<p>3&#8239;tablets daily for 2 months (initial phase).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 55&#8211;69 kg)</p>\n<p>4&#8239;tablets daily for 2 months (initial phase).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 70 kg and above)</p>\n<p>5&#8239;tablets daily for 2 months (initial phase).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>Tablet quantities refer to the number of <i>Voractiv</i>\n<tm tmtype=\"reg\"/> Tablets which should be taken. Each <i>Voractiv</i>\n<tm tmtype=\"reg\"/> Tablet contains ethambutol hydrochloride 275&#8239;mg, isoniazid 75&#8239;mg, pyrazinamide 400&#8239;mg and rifampicin 150&#8239;mg.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP97091\" outputclass=\"cautions\" rev=\"1.13\" parent=\"/drugs/ethambutol-with-isoniazid-pyrazinamide-and-rifampicin\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Peripheral neuropathy</p>\n<p>The risk of peripheral neuropathy may be increased by high doses of isoniazid; pyridoxine should, therefore, be considered for those receiving <i>Voractiv</i>\n<tm tmtype=\"reg\"/> 5 tablets daily.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP97002-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/ethambutol-with-isoniazid-pyrazinamide-and-rifampicin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP97227\" title=\"Tablet\" namespace=\"/drugs/ethambutol-with-isoniazid-pyrazinamide-and-rifampicin/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"3\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_165\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/isoniazid\" title=\"Isoniazid\" count=\"1\" rel=\"link\">Isoniazid</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_201\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/rifamycins/rifampicin\" title=\"Rifampicin\" count=\"1\" rel=\"link\">Rifampicin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_192\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/pyrazinamide\" title=\"Pyrazinamide\" count=\"1\" rel=\"link\">Pyrazinamide</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1304\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/ethambutol\" title=\"Ethambutol\" count=\"1\" rel=\"link\">Ethambutol</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP3604\" namespace=\"/drugs/ethambutol-hydrochloride\" title=\"ETHAMBUTOL HYDROCHLORIDE\" count=\"1\" rel=\"link\">ETHAMBUTOL HYDROCHLORIDE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP3608\" namespace=\"/drugs/isoniazid\" title=\"ISONIAZID\" count=\"1\" rel=\"link\">ISONIAZID</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP3612\" namespace=\"/drugs/pyrazinamide\" title=\"PYRAZINAMIDE\" count=\"1\" rel=\"link\">PYRAZINAMIDE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP3619\" namespace=\"/drugs/rifampicin\" title=\"RIFAMPICIN\" count=\"1\" rel=\"link\">RIFAMPICIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP97227\" namespace=\"/drugs/ethambutol-with-isoniazid-pyrazinamide-and-rifampicin/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP97002",
    "outputclass": "drug",
    "rev": "1.22",
    "type": "drug",
    "namespace": "/drugs/ethambutol-with-isoniazid-pyrazinamide-and-rifampicin",
    "basename": "ethambutol-with-isoniazid-pyrazinamide-and-rifampicin",
    "title": "ETHAMBUTOL WITH ISONIAZID, PYRAZINAMIDE AND RIFAMPICIN",
    "interactants": [
        {
            "id": "bnf_int_165",
            "label": "Isoniazid"
        },
        {
            "id": "bnf_int_201",
            "label": "Rifampicin"
        },
        {
            "id": "bnf_int_192",
            "label": "Pyrazinamide"
        },
        {
            "id": "bnf_int_1304",
            "label": "Ethambutol"
        }
    ],
    "constituents": [
        {
            "id": "PHP3604",
            "label": "ethambutol hydrochloride"
        },
        {
            "id": "PHP3608",
            "label": "isoniazid"
        },
        {
            "id": "PHP3612",
            "label": "pyrazinamide"
        },
        {
            "id": "PHP3619",
            "label": "rifampicin"
        }
    ],
    "drugClassification": [
        "Antimycobacterials",
        "Hydrazines",
        "Rifamycins"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Initial treatment of tuberculosis",
                        "html": "Initial treatment of tuberculosis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "2 tablets daily for 2 months (initial phase).",
                        "html": "<p>2&#8239;tablets daily for 2 months (initial phase).</p>",
                        "ageGroup": "(body-weight 30&#8211;39 kg)"
                    },
                    {
                        "textContent": "3 tablets daily for 2 months (initial phase).",
                        "html": "<p>3&#8239;tablets daily for 2 months (initial phase).</p>",
                        "ageGroup": "(body-weight 40&#8211;54 kg)"
                    },
                    {
                        "textContent": "4 tablets daily for 2 months (initial phase).",
                        "html": "<p>4&#8239;tablets daily for 2 months (initial phase).</p>",
                        "ageGroup": "(body-weight 55&#8211;69 kg)"
                    },
                    {
                        "textContent": "5 tablets daily for 2 months (initial phase).",
                        "html": "<p>5&#8239;tablets daily for 2 months (initial phase).</p>",
                        "ageGroup": "(body-weight 70 kg and above)"
                    }
                ]
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "Tablet quantities refer to the number of Voractiv Tablets which should be taken. Each Voractiv Tablet contains ethambutol hydrochloride 275 mg, isoniazid 75 mg, pyrazinamide 400 mg and rifampicin 150 mg.",
                "html": "<p>Tablet quantities refer to the number of <i>Voractiv</i>\n<tm tmtype=\"reg\"/> Tablets which should be taken. Each <i>Voractiv</i>\n<tm tmtype=\"reg\"/> Tablet contains ethambutol hydrochloride 275&#8239;mg, isoniazid 75&#8239;mg, pyrazinamide 400&#8239;mg and rifampicin 150&#8239;mg.</p>"
            }
        ]
    },
    "cautions": {
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Peripheral neuropathy",
                "textContent": "The risk of peripheral neuropathy may be increased by high doses of isoniazid; pyridoxine should, therefore, be considered for those receiving Voractiv 5 tablets daily.",
                "html": "<p>The risk of peripheral neuropathy may be increased by high doses of isoniazid; pyridoxine should, therefore, be considered for those receiving <i>Voractiv</i>\n<tm tmtype=\"reg\"/> 5 tablets daily.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP97227",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_165",
                "label": "Isoniazid",
                "type": "interaction"
            },
            {
                "id": "bnf_int_201",
                "label": "Rifampicin",
                "type": "interaction"
            },
            {
                "id": "bnf_int_192",
                "label": "Pyrazinamide",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1304",
                "label": "Ethambutol",
                "type": "interaction"
            }
        ],
        "drug": [
            {
                "id": "PHP3604",
                "label": "ETHAMBUTOL HYDROCHLORIDE",
                "type": "drug"
            },
            {
                "id": "PHP3608",
                "label": "ISONIAZID",
                "type": "drug"
            },
            {
                "id": "PHP3612",
                "label": "PYRAZINAMIDE",
                "type": "drug"
            },
            {
                "id": "PHP3619",
                "label": "RIFAMPICIN",
                "type": "drug"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP97227",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}